Scenarios that move SLN

Silence Therapeutics Plc - American Depository Share

Scenarios that move SLN: 2 analyses, 0 positive, 2 negative.

1. 2026-09-25 · ADARx Pharmaceuticals prices upsized $446.3 million initial public offering — ▼ · impact -28 · confidence low · horizon weeks
2. 2026-09-07 · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▼ · impact -70 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing